MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Mechanical Peripheral Stimulation for the Treatment of Gait Disorders in Patients with Parkinson’s Disease (GONDOPARK): A Multi-centre, Double-blind, Crossover Randomized Controlled Trial

    MD. de Pandis, TC. Carlo, SP. Proietti, LL. Leonardi, MG. Gaglione, MC. Casali, LD. Di Biase, MG. Galli, MG. Goffredo, FS. Stocchi (Roma, Italy)

    Objective: The interventional clinical study GONDOPARK aims at evaluating the effects of AMPS treatment on gait speed and gait-related disorders in subjects with PD.The interventional…
  • 2025 International Congress

    A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies

    C. Gibbons, T. Levine, B. Bellaire, R. Freeman (boston, USA)

    Objective: To report the quantitative change in cutaneous phosphorylated alpha-synuclein (P-SYN) deposition over time in patients with dementia with Lewy bodies (DLB) in a longitudinal…
  • 2025 International Congress

    Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

    S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)

    Objective: To study the clinical phenotype of all patients with ATP 1A3 mutation in the genetic study Background: ATP1A3 is associated with a broad spectrum…
  • 2025 International Congress

    Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

    Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)

    Objective: We retrospectively analyzed the medical records of all parkinsonism patients admitted to our clinic in 2024, examining neurological, psychiatric, radiological, and demographic characteristics of…
  • 2025 International Congress

    Frontal and Motor TMS Evoked Potentials Predict Response to Ventriculoperitoneal Shunt in NPH

    T. Davidi, S. Anis, Y. Zauberman, T. Fay-Karmon, A. Saar, N. Zifman, H. Fogel, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: Assess the ability of neurophysiological measure of TMS evoked potentials to predicts response to shunting in NPH. Background: NPH is an age-related condition of…
  • 2025 International Congress

    Balance confidence may not accurately assess fall risk in atypical parkinsonism

    G. Arleth, E. Buxton, R. Bryant, M. Ivancic, N. Browner, J. Shurer, M. Sklerov (Chapel Hill, USA)

    Objective: Objective: To examine if balance confidence, measured by the Activities-specific Balance Confidence (ABC) scale, reflects fall frequency in atypical parkinsonian syndromes (APS), namely multiple…
  • 2025 International Congress

    Anal Sphincter EMG changes can Progress over Time and can be considered as a Prognostic Marker in MSA

    L. Lei, J. Bermejillo, P. Malladi, J. Panicker, A. Batla (London, United Kingdom)

    Objective: To assess the usefulness of repeat anal sphincter EMG for prognostication of MSA Background: External anal sphincter (EAS) electromyography (EMG) is an established method…
  • 2025 International Congress

    Novel Heterozygous Variant in DCTN1 Associated with Perry Syndrome

    D. Yang, Y. Zhang, Z. Cen, W. Luo (Hangzhou, China)

    Objective: To identify novel mutations in DCTN1 associated with autosomal dominant Perry syndrome and investigate their potential pathogenic mechanisms. Background: Perry syndrome is a neurodegenerative…
  • 2025 International Congress

    Brain perfusion patterns associated with motor symptoms in multiple system atrophy

    Y. Nakano, A. Sugiyama, S. Hirano, Y. Nakagawa, M. Tamura, T. Yamamoto, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, S. Kuwabara, Y. Kitayama (Chiba, Japan)

    Objective: There is a need for objective methods to assess disease progression in multiple system atrophy (MSA). This study aimed to identify brain perfusion patterns…
  • 2025 International Congress

    Alpha Synuclein Seeding Activity Drives Disease Heterogeneity in an Animal Model of Multiple System Atrophy

    A. Shafique, N. Silver, A. Mao, R. Ferry, I. Martinez-Valbuena, J. Watts, G. Kovacs, N. Visanji (Toronto, Canada)

    Objective: To examine the impact of multiple system atrophy (MSA) brain-derived alpha synuclein (αSyn) with diverse seeding activities in an inoculation-based animal model. Background: We…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley